---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-181717"
form_type: "8-K"
ticker: "SLNO"
cik: "0001484565"
company_name: "SOLENO THERAPEUTICS INC"
filed_at: "2024-07-19T23:59:59+00:00"
generated_at: "2026-05-31T19:00:19.357084+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Soleno Therapeutics enters $150M at-the-market equity offering with Jefferies

## Summary
- Soleno may sell up to $150M of common stock from time to time under Sale Agreement with Jefferies.
- Jefferies will use commercially reasonable efforts to sell shares as an at-the-market offering.
- Commission of 3.0% of gross proceeds; Soleno also reimburses certain expenses.
- Offering made under existing S-3ASR registration statement filed on Jan 2024.

## SEC filing metadata
- accession: 0001193125-24-181717
- form_type: 8-K
- ticker: SLNO
- cik: 0001484565
- company_name: SOLENO THERAPEUTICS INC
- filed_at: 2024-07-19T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484565/000119312524181717/0001193125-24-181717-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484565/000119312524181717/d817873d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-181717
- JSON: https://secwatch.observer/filing/0001193125-24-181717.json
- Plain text: https://secwatch.observer/filing/0001193125-24-181717.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.